Clinical Trial Update: Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TG4040 therapeutic vaccine in combination with pegylated interferon and ribavirin shows efficacy signals in chronic hepatitis C infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• TG4040

Snippet

Sponsor: Transgene | Conditions: Chronic Hepatitis C Infection | Phase 2 | Status: COMPLETED